Managing people with sickle cell disease and complex chronic pain is difficult and requires some trial and error, said C. Patrick Carroll, MD, director of psychiatric services, Sickle Cell Center for Adults, associate professor of psychiatry, Johns Hopkins Medicine.
Managing people with sickle cell disease and complex chronic pain is difficult and requires some trial and error, said C. Patrick Carroll, MD, director of psychiatric services, Sickle Cell Center for Adults, associate professor of psychiatry, Johns Hopkins Medicine.
Transcript
For patients with sickle cell disease who have the highest levels of pain, what treatment options need to be considered if their pain is not properly managed?
Well, the highest levels of pain in the question is tricky, because sickle cell disease can produce all manner of pain with all kinds of time courses. So, you can have some people who have intermittent crisis pain or acute pain. And then there are people who have very frequent crises. And then there are people who have chronic pain, and sometimes that can be from a complication of sickle cell disease, like avascular necrosis, and sometimes you can't find any particular cause for it, except that they have sickle cell disease. And then you can have any combination of those.
And so, much depends on the actual clinical situation. So, if you have someone who's having frequent crises, the first thing is can you manage the sickle cell disease any better? One of the questions I'm often asking my team is, are we treating this patient for crises they shouldn't be happening? Are they on hydroxyurea? Are they getting any other former disease-modifying therapy? Or are they worth a try on chronic transfusion therapy? Anything we can do to try to help the acute pain, prevent it, but also to help shift people more towards an outpatient care strategy with a multidisciplinary team rather than being cared for in emergency rooms and inpatient hospitals.
And then if you can achieve that, the question it really depends on what's been tried and what has failed. And I am a big fan of declaring failure when things haven’t worked. So, if a person's been treated in a particular way, it doesn't seem to have worked, then the thing to often do is to stop doing that rather than do more of it and try something different. But the evidence base behind any treatments for chronic pain in particular is very poor. And so, we're very much in a trial-and-error process more trying to manage people with complex chronic pain.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
High HSP60 Expression Signals Poor Prognosis, Aggressive Tumors in Ovarian Cancer
January 16th 2025High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a prognostic biomarker.
Read More